Y43.1 is the ICD-10 code for Antineoplastic antimetabolites. It is a four-character subcategory of Y43 (Primarily systemic agents), the most specific level in the WHO edition. It belongs to the block Y40–Y59 (Drugs, medicaments and biological substances causing adverse effects in therapeutic use) in Chapter XX, External causes of morbidity and mortality.
- Code type
- Subcategory (4 characters)
- Chapter
- XX · V01–Y98
- Classification
- WHO ICD-10, 2019 version
What Y43.1 includes
Conditions and terms that are coded here.
- Cytarabine
Y43.1 in national editions
Countries report with their own edition of ICD-10. Most keep the WHO code and add more specific codes beneath it.
Y43.1Antimétabolites antitumoraux
Y43.1antineoplastische antimetabolieten
Based on the World Health Organization’s International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10), 2019 version, and the national editions published by each country’s health authority. This page is a reference, not coding advice; follow your national coding rules when you report.
Look up another code
Stop looking codes up by hand
Docdemic listens to the consultation, writes the note and suggests the diagnosis and procedure codes that fit it, each one checked against your country’s official code list.
Try Docdemic free